Subscribe To
4d pharma sees early success as phase i/ii cancer trial hits its efficacy target early
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) said it had hit its primary efficacy target in a phase I/II trial...
March 23, 2022, 3:56 am
4d pharma receives us regulatory green light for phase i trial of its parkinson's disease candidates
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has received the green light for a first-in-human trial of its Pa...
February 22, 2022, 2:56 am
4d pharma receives us regulatory green light for phase i trial of its parkinson's disease candidates
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has received the green light for a first-in-human trial of its Pa...
February 22, 2022, 2:56 am
4d pharma receives us regulatory green light for phase i trial of its parkinson's disease candidates
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has received the green light for a first-in-human trial of its Pa...
February 22, 2022, 2:56 am
4d pharma hails 'highly encouraging' data from its early-stage asthma trial
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has shared 'highly encouraging' follow-up data from its early-sta...
January 27, 2022, 2:39 am
4d pharma hails 'highly encouraging' data from its early-stage asthma trial
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has shared 'highly encouraging' follow-up data from its early-sta...
January 27, 2022, 2:39 am
4d pharma hails 'highly encouraging' data from its early-stage asthma trial
4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has shared 'highly encouraging' follow-up data from its early-sta...
January 27, 2022, 2:39 am